S

Semma Therapeutics

75 employees

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2015

Funding rounds raised

Total raised

$114M

from 14 investors over 14 rounds

S

Semma Therapeutics raised $114M on November 29, 2017

Investors: Sinopharm Capital 国药资本, F-Prime Capital Partners, JDRF T1D Fund, Wu Capital (双湖资本), MPM Capital, Cowen Inc. and ORI Capital Limited

S

Semma Therapeutics raised undisclosed on March 23, 2017

Investors: MPM Capital, JDRF T1D Fund and F-Prime Capital Partners

S

Semma Therapeutics raised $44M on March 24, 2015

Investors: MPM Capital, F-Prime Capital Partners and ARCH Venture Partners

S

Semma Therapeutics raised undisclosed on January 1, 2014

Investors: F-Prime Capital Partners

FAQ